Peter Obami is currently employed at Barking, Havering, and Redbridge University Hospitals NHS FT since December 2023, holding the title of Biomedical scientist - Cellular pathology. prior to this, He also held the position of Biomedical scientist at the University Hospital Southampton NHS FT. Peter held the position of Lead Medical laboratory scientist, while working at Decure medical laboratory and diagnostics services limited, Abuja Nigeria. Peter held this dynamic role for 6 months. He also worked as a medical laboratory scientist at Kubwa General Hospital Abuja, Nigeria. Peter completed a Bachelor of Medical Laboratory Science (BMLS) degree from Ambrose Alli University, Ekpoma Nigeria, and a Masters degree with distinction in public health from the Prestigious University of Sunderland in London United Kingdom.
Nirav is the Clinical IT lead for Cellular Pathology at Derbyshire Pathology. Following the successful recent implementation of a new LIMS system, he is overseeing the roll-out of the digital pathology system. Nirav is also a member of the core management group and AI working group for PathLake Plus.
Currently, Nirav sits on the Royal College of Pathologists Working Group on Cancer Services and is treasurer elect for the British Association of Gynaecological Pathologists.
Nirav received an MBA from the London Business School and has spent time in banking, Healthcare and Life Sciences venture capital analysing businesses for investment opportunities. His interests include operational management and workflow in healthcare.
Tom completed a PhD with Prof. Margaret Frame at IGMM in Edinburgh, followed by a post-doctoral fellowship with Prof Sergio Quezada at UCL Cancer Institute. Tom’s work has focused on multiplex immune fluorescence and pathology-based imaging with AI and spatial modelling techniques, to interrogate the tumour immune response and wider tumour microenvironment. This has carried him to The Royal Marsden and the ICR, where today he is the scientific lead of the Integrated Pathology Unit (IPU). His current research focuses on development of AI and tissue hybridisation imaging modalities at large scale, for meaningful clinical interpretation. His tissue agonistic approaches within the IPU have led to research in 50+ different disease contexts, including paediatric neuroblastoma, TNBC, NSCLC, bladder, prostate, colorectal and oesophageal cancers.
Dr Heba Sailem is a Senior Lecturer of Biomedical AI and Data Science at the School of Cancer and Pharmaceutical Sciences at King’s College London.
Her research is focused on developing artificial intelligence and bioinformatics approaches to enable personalised cancer patient treatment. Her group work is highly interdisciplinary and combines insights from histopathology, genetics, pharmaceutical medicine, and cell biology.
Before joining King's, she worked between the Institute of Biomedical Engineering and Big Data Institute at the University of Oxford. There, she has developed several machine learning approaches to tackle challenges in pattern recognition and interpretability of large-scale biomedical image data and pioneered knowledge-driven machine learning for utilising prior knowledge when analysing large scale biomedical data which won the Early Bioinformatician Award.
Prof. Sarah Coupland is a senior Consultant Histopathologist at the Liverpool University Foundation Hospital Trusts, UK, with expertise in Ophthalmic Pathology, Haematopathology, Molecular and Digital Pathology, and Biobanking.
In 2006, Prof. Coupland established the ‘Liverpool-Ocular-Oncology-Research-Group’ (www.loorg.org), a multidisciplinary team, focussing on ocular melanomas, lymphomas, and other eye cancers. She is the ‘George Holt Chair of Pathology’ at the University of Liverpool (>2013).
Prof. Coupland is the current Vice President (Communications) and Genomics Co-Lead of the Royal College of Pathologists (RCPath). She is also General Secretary of the “Pathological Society of Great Britain and Ireland”.
She has published ~350 scientific articles (H-index:63/Scopus), has written ~150 Chapters, including some within the UICC/TNM Staging system for Ophthalmic Tumours, as well as the WHO ‘Blue’ Tumour Volumes (Eye, Haematopathology, Skin and Paediatric cancers).
She has won several awards for research and teaching, including the International Council of Ophthalmology's ‘Eye Pathology Award’ & the 2019 RCPath Excellence Award. She was included in the “Pathologist Power Lists” of 2019, 2020, 2021 and 2023, and was also listed in the “Top 100 Influential Women in Ophthalmology” in 2021.
Prof Coupland was awarded an Honorary Fellowship of the Royal College of Ophthalmologists (FRCOphth) on Sept. 8th, 2023, for her significant contributions to Ophthalmic Pathology
Kishore graduated from MAHE University in India in 1988, where he obtained his medical degree, he pursued further specialisation and completed his MD in pathology at the same university.
To expand his expertise, Kishore sought additional training in pathology at the West Midlands Deanery. Since 2010, he has held the position of Consultant Pathologist at UHCW (University Hospitals Coventry & Warwickshire). Alongside his role as a consultant, Kishore has become Lead of Gastrointestinal, HPB (hepato-pancreatico-biliary), and Renal Pathology at UHCW.
Kishore was an early adopter of digital pathology, he is actively involved in research, particularly exploring the utility of AI in digital pathology.
Dr Ginder is a consultant radiologist with an interest in Musculoskeletal Imaging. He is a previous Clinical Director of Imaging at SaTH and advocate of using digital solutions to optimise workflow in clinical environments.
Senior postdoctoral researcher specializing in digital pathology and image analysis within molecular pathology. My work has significantly contributed to understanding cancer biology, particularly through the integration of digital pathology with cell biology. Key achievements include pioneering research on the spatial distribution of invasive cancer cells in tumours and exploring the impact of extracellular matrix topography on metastasis. Skilled in digital pathology tools like QuPath, Matlab, and FIJI ImageJ, I have developed customized analytical techniques essential for advanced cancer research. My collaborative projects with industry leaders have further enriched my expertise, particularly in AI applications in molecular profiling.
Volodymyr was trained in Biochemistry at Imperial College London. Initially, he researched immune signalling at GSK, Stevenage before moving towards data science. He has since undertaken artificial intelligence (AI) projects at JIC and TSL, Norwich, investigating plant development and pathogenesis, respectively. For his PhD research, he combined experiences with AI and immunology to better predict treatment response in Follicular Lymphoma, a common yet little studied cancer. Volodymyr's work has been presented at the European Congress of Digital Pathology, IBMC of the Chinese Academy of Sciences and is the focus of a partnership with a major pharmaceutical company.
After starting his IT career in the corporate world Kieran has focussed on transforming healthcare with new technologies and improving the patient journey through integration and paperless working, now onto a network level. Previously as a Genomics IT lead and now as a Pathology IT Lead for a large tertiary referral hospital which sits within one of the largest Pathology networks and Genomics hubs in England, this drive for improvement brings together systems like never before, with Kieran actively involved in their development, implementation and day to day working.
Peter Obami is currently employed at Barking, Havering, and Redbridge University Hospitals NHS FT since December 2023, holding the title of Biomedical scientist - Cellular pathology. prior to this, He also held the position of Biomedical scientist at the University Hospital Southampton NHS FT. Peter held the position of Lead Medical laboratory scientist, while working at Decure medical laboratory and diagnostics services limited, Abuja Nigeria. Peter held this dynamic role for 6 months. He also worked as a medical laboratory scientist at Kubwa General Hospital Abuja, Nigeria. Peter completed a Bachelor of Medical Laboratory Science (BMLS) degree from Ambrose Alli University, Ekpoma Nigeria, and a Masters degree with distinction in public health from the Prestigious University of Sunderland in London United Kingdom.
Nirav is the Clinical IT lead for Cellular Pathology at Derbyshire Pathology. Following the successful recent implementation of a new LIMS system, he is overseeing the roll-out of the digital pathology system. Nirav is also a member of the core management group and AI working group for PathLake Plus.
Currently, Nirav sits on the Royal College of Pathologists Working Group on Cancer Services and is treasurer elect for the British Association of Gynaecological Pathologists.
Nirav received an MBA from the London Business School and has spent time in banking, Healthcare and Life Sciences venture capital analysing businesses for investment opportunities. His interests include operational management and workflow in healthcare.
Devika Gholap, the Managing Director at OptraScan, and a seasoned professional in the medical devices industry based in San Francisco, is a dynamic leader with a fervor for cutting-edge technology. Armed with an MBA from Columbia Business School and a Bachelor’s in Biomedical Engineering and boasting many years of experience, Devika excels in product development and innovation. Her leadership has spearheaded the successful launch of several groundbreaking medical devices, positioning her teams at the forefront of the industry. Known for her strategic vision, Devika has significantly contributed to the growth of her organizations, which include Medtronic and BD. Outside the boardroom, she is an advocate for STEM education, reflecting her commitment to fostering the next generation of innovators in the medical devices sector.
Richard is the Founder of RosettaPath, a science-based pathology consultancy providing research and toxicologic pathology expertise for biotech, pharmaceutical, CRO, software vendors and academia. He applies digital pathology, image analysis and AI to generate quantitative data to improve biological understanding, translational and predictive value of models, decision making and efficiency of medicine development.
Prior to RosettaPath, Richard led the Global Pathology team within CPSS at AstraZeneca. He qualified in Veterinary medicine from the University of Cambridge, completed a DPhil at Oxford in experimental pathology and immunology, was Head of the UK Pathology department at GSK and is board certified in pathology (FRCPath, DipECVP) and toxicology (DABT).
Nipun is a co-inventor of a direct bacterial plasmonic PCR technology, that promises to revolutionise disease detection and management, through remote testing of microbial disease with under 12-minute turnaround times. He did his PhD in Physics at the Cavendish Laboratory and is currently co-investigator of a medical research council funded project for developing confidence in the concept of the plasmonic PCR machine built at his laboratory. Previously Nipun has worked as a volunteer epidemiologist with the principal scientific advisor to the prime minister of India and health ministry. His latest endeavor Rapidx Bio is an organisation that is currently spinning out from the Cavendish Laboratory, to translate the cutting edge IOT-connected plasmonic PCR technology for urinary tract and sexually transmitted infections in point-of-need and point-of-care settings.
Nichole Villeneuve is a Consultant Biomedical Scientist with 35 years’ experience working in cervical cancer screening. She has worked in Canada and the UK and currently works at North Bristol NHS Trust in a large cytology laboratory which delivers regional HPV testing and cervical cytology services for the NHS Cervical Screening Programme. Nichole is the deputy lead for cervical screening, and the cytology clinical governance lead. She holds an honorary contract with NHS England & Improvement as a Professional and Clinical Advisor for the Cervical Screening Quality Assurance Service.
Keith Miller is a Fellow of the Institute of Biomedical Sciences and has had a long and distinguished career in the field of immunohistochemistry (IHC). During his four decades at University College London as a Medical Scientist in Pathology, Keith developed UCL-Advanced Diagnostics and established an International External Quality Assessment Scheme for IHC (UKNEQAS-IHC&ISH). In his latter years at UCL, Keith was involved with developing digital pathology and after retirement, is assisting the Consortium for Analytical Standardization in Immunohistochemistry.
Jake is an experienced and certified Product Manager for IVD and technology-based products in healthcare. He has a scientific background with over 10 years laboratory experience which included holding a Guest Lecturing position for 6 years; delivering course content to the next generation of Biomedical Scientist. Jake has been Product Manager at Clinisys for over two years and in that time has been instrumental in introducing and releasing new and innovative solutions for Clinisys customers.
